Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04295798 · ClinicalTrials.gov registry record · NA

Optimizing tDCS to Improve Dual Task Gait and Balance

A NA study of Aging, sponsored by Hebrew SeniorLife.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT04295798 is a NA study of Aging that has completed, run by Hebrew SeniorLife. The registered enrollment target is 29 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04295798, a NA study of Aging, has completed, sponsored by Hebrew SeniorLife.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine the acute effects of single sessions of optimized tDCS, conventional tDCS, and sham stimulation on dual task standing and walking in older adults who are free of overt disease yet who present with poor baseline dual task performance.

Conditions Studied

Interventions

  • DEVICE Conventional tDCS
  • DEVICE Optimized tDCS
  • DEVICE Conventional Sham
  • DEVICE Optimized Sham

Study Locations (1)

Massachusetts

  • Hebrew Rehabilitation Center - Roslindale

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2020-02-10
Est. Completion 2023-03-02
Phase NA

Sponsor

Hebrew SeniorLife

32 total trials

What the Registry Record Tells You About NCT04295798

The ClinicalTrials.gov registry entry for NCT04295798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is Hebrew SeniorLife, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 4 interventions - of which Conventional tDCS is the first listed.

NCT04295798 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04295798 about?

NCT04295798 is a clinical study titled "Optimizing tDCS to Improve Dual Task Gait and Balance". The objective of this study is to determine the acute effects of single sessions of optimized tDCS, conventional tDCS, and sham stimulation on dual task standing and walking in older adults who are free of overt disease yet who present with poor baseline dual task performance.

What is the current status of trial NCT04295798?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2020-02-10. Estimated completion is 2023-03-02.

What conditions does trial NCT04295798 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT04295798?

The interventions under investigation include: Conventional tDCS (DEVICE), Optimized tDCS (DEVICE), Conventional Sham (DEVICE), Optimized Sham (DEVICE).

Who is sponsoring clinical trial NCT04295798?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04295798 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.